Limited pelvic radiotherapy in postoperative Carcinoma Uterine Cervix and Endometrium. A retrospective study.
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2024 - 2025
Project Lead
Hadrian Noel Alexander
Authors
Hadrian Noel Alexander, Avinash H Udayashankara, Silpa Johnson, Nirmala Srikantia, John Michael Ra
Project Status
completed
Project Type
Retrospective cohort study